![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](hy2118contents.gif)
Acta Cryst. (2008). E64, m460-m461 [ doi:10.1107/S1600536808003747 ]
![[kappa]](/logos/entities/kappa_rmgif.gif)
2O,O')bis(nicotinamide-N1)zinc(II) monohydrateAbstract: The title compound, [Zn(C7H4FO2)2(C6H6N2O)2]·H2O, is a monomeric complex. It contains two 4-fluorobenzoate and two nicotinamide ligands and one uncoordinated water molecule. The 4-fluorobenzoates act as bidentate chelating ligands, while the nicotinamides are monodentate. The six-coordinate geometry around the ZnII atom may be described as highly distorted octahedral, with the two nicotinamide ligands arranged cis. Intermolecular O-H
O and N-HO hydrogen bonds link the molecules into a supramolecular structure.
Online 6 February 2008
Copyright © International Union of Crystallography
IUCr Webmaster